TEMPORARILY_NOT_AVAILABLENCT06169176
RAPA-501 Therapy of ALS Expanded Access Protocol
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rapa Therapeutics LLC
- Principal Investigator
- Daniel H Fowler, M.D.Rapa Therapeutics LLC
- Intervention
- RAPA-501 Autologous T stem cells(other)
- Eligibility
- 18 years · All sexes
Study locations (10)
- Barrow Neurological Institute, Phoenix, Arizona, United States
- Mayo Clinic Hospital Phoenix, Scottsdale, Arizona, United States
- University of California Irvine Health, Irvine, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Emory University, Atlanta, Georgia, United States
- University of Iowa Health Care, Iowa City, Iowa, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Providence Portland Medical Center, Portland, Oregon, United States
Collaborators
Massachusetts General Hospital · National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06169176 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)